Clinical outcomes of Sacubitril/Valsartan in patients with acute heart failure: A multi-institution study
Background: The effectiveness and safety of initiating sacubitril/valsartan therapy among patients who are hospitalized for acute heart failure (HF) is unclear. Methods: A cohort of 3736 patients with HF with reduced ejection fraction (HFrEF) hospitalized for acute HF was identified from Chang Gung...
Main Authors: | Dong-Yi Chen, Chun-Chi Chen, Chi-Nan Tseng, Shao-Wei Chen, Shang-Hung Chang, Wen-Kuan Huang, Ming-Shien Wen, Ming-Jer Hsieh, I-Chang Hsieh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537021004296 |
Similar Items
-
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
by: Yandrapalli S, et al.
Published: (2017-10-01) -
Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
by: Charlotte Nordberg Backelin, et al.
Published: (2020-06-01) -
Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real‐world study
by: Wenwen Chen, et al.
Published: (2021-10-01) -
Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
by: Gregor Poglajen, et al.
Published: (2020-07-01) -
Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
by: Alex Heyse, et al.
Published: (2019-12-01)